Company Filing History:
Years Active: 2004
Title: Jan Strömbom: Innovator in Therapeutic Formulations
Introduction
Jan Strömbom is a notable inventor based in Vattholma, Sweden. He has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of urinary bladder conditions. His innovative approach has led to the development of a unique therapeutic formulation.
Latest Patents
Jan Strömbom holds a patent for a therapeutic formulation for administering tolterodine with controlled release. This invention focuses on a method of treating an unstable or overactive urinary bladder by utilizing tolterodine or a related compound. The formulation is designed to maintain a substantially constant serum level of the active ingredient for at least 24 hours, enhancing the effectiveness of the treatment.
Career Highlights
Throughout his career, Jan has been associated with Pharmacia AB, where he has contributed to various research and development projects. His work has been instrumental in advancing therapeutic options for patients suffering from urinary bladder disorders.
Collaborations
Jan Strömbom has collaborated with several professionals in his field, including Bo Kreilgård and Lene Orup Jacobsen. These partnerships have fostered innovation and have been crucial in the development of his patented formulations.
Conclusion
Jan Strömbom's contributions to therapeutic formulations exemplify the impact of innovative thinking in the pharmaceutical industry. His work continues to influence the treatment of urinary bladder conditions, showcasing the importance of research and development in healthcare.